Imke Redeker (I Redeker)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 11

Top Topics

Disease Activity

Rheumatoid Arthritis

Magnetic Resonance Imaging

Top Venues

Therapeutic advances in musculoskeletal disease

Arthritis research & therapy

Arthritis & rheumatology (Hoboken, N.J.)

This page only lists publications with an associated author ORCID identifier.

Publications

Imke Redeker, Stefan Moustakis, Styliani Tsiami, Xenofon Baraliakos, David Kiefer, Ioana Andreica, Björn Buehring, Jüergen Braun, Uta Kiltz
A Bayesian model to analyse the association of comorbidities with biosimilar treatment retention in a non-medical switch scenario in patients with inflammatory rheumatic musculoskeletal diseases. Arthritis research & therapy 26 (1) (2024)
Imke Redeker, Robert B M Landewe, Désirée Mfm van der Heijde, Josef S Smolen, Annelies Boonen, Maxime Dougados, Jüergen Braun, Uta Kiltz
Impact of disease outcomes on the Assessment of SpondyloArthritis International Society Health Index (ASAS HI): a Bayesian network analysis of the DESIR cohort. RMD open 9 (4) (2023)
Imke Redeker, Stefan Moustakis, Styliani Tsiami, Xenofon Baraliakos, Ioana Andreica, Bjoern Buehring, Jüergen Braun, Uta Kiltz
Treatment with adalimumab in patients with chronic inflammatory rheumatic diseases: a study of treatment trajectories on a patient level in routine care. Therapeutic advances in musculoskeletal disease 15 (2023)
Imke Redeker, Robert B M Landewe, Désirée Mfm van der Heijde, Josef S Smolen, Annelies Boonen, Maxime Dougados, Jüergen Braun, Uta Kiltz
Impact of disease outcomes on the Assessment of SpondyloArthritis International Society Health Index (ASAS HI): a Bayesian network analysis of the DESIR cohort. RMD open 9 (4) (2023)
Imke Redeker, Robert B M Landewe, Désirée Mfm van der Heijde, Josef S Smolen, Annelies Boonen, Maxime Dougados, Jüergen Braun, Uta Kiltz
Impact of disease outcomes on the Assessment of SpondyloArthritis International Society Health Index (ASAS HI): a Bayesian network analysis of the DESIR cohort. RMD open 9 (4) (2023)
Imke Redeker, Anja Strangfeld, Johanna Callhoff, Ursula Marschall, Angela Zink, Xenofon Baraliakos
Maternal and infant outcomes in pregnancies of women with axial spondyloarthritis compared with matched controls: results from nationwide health insurance data. RMD open 8 (2) (2022)
Imke Redeker, Katinka Albrecht, Joern Kekow, Gerd-Rüdiger R Burmester, Jüergen Braun, Martin Schäfer, Angela Zink, Anja Strangfeld
Risk of herpes zoster (shingles) in patients with rheumatoid arthritis under biologic, targeted synthetic and conventional synthetic DMARD treatment: data from the German RABBIT register. Annals of the rheumatic diseases (2021)
Denis Poddubnyy, Valeria Rios Rodriguez, Laura Spiller, Mikhail Protopopov, Valeria Rios Rodriguez, Burkhard Muche, Judith Rademacher, Murat Torgutalp, Janis Lucas Vahldiek, Joachim Sieper, Imke Redeker
Diagnosing axial spondyloarthritis: estimation of the disease probability in patients with a priori different likelihoods of the diagnosis. Rheumatology (Oxford, England) 60 (11) (2021)
Xenofon Baraliakos, A Ghadir, Martin Fruth, Uta Kiltz, Imke Redeker, Jüergen Braun
Which Magnetic Resonance Imaging Lesions in the Sacroiliac Joints Are Most Relevant for Diagnosing Axial Spondyloarthritis? A Prospective Study Comparing Rheumatologists' Evaluations With Radiologists' Findings. Arthritis & rheumatology (Hoboken, N.J.) 73 (5) (2021)
Imke Redeker, Johanna Callhoff, Falk Hoffmann, Ursula Marschall, Hildrun Haibel, Joachim Sieper, Angela Zink, Denis Poddubnyy
The prevalence and impact of comorbidities on patients with axial spondyloarthritis: results from a nationwide population-based study. Arthritis research & therapy 22 (1) (2020)
Imke Redeker, Britta Siegmund, Kamran Ghoreschi, Uwe Pleyer, Johanna Callhoff, Falk Hoffmann, Ursula Marschall, Hildrun Haibel, Joachim Sieper, Angela Zink, Denis Poddubnyy
The impact of extra-musculoskeletal manifestations on disease activity, functional status, and treatment patterns in patients with axial spondyloarthritis: results from a nationwide population-based study. Therapeutic advances in musculoskeletal disease 12 (2020)